Join
Live feed
·
INSIDERFilingvia Quantisnow
Turning Point Therapeutics Inc. logo

SEC Form 4: Athena Countouriotis was granted 22,617 units of Common Stock, increasing ownership by 82% to 50,195 units

ByQuantisnow·Wall Street's wire, on your screen.
TPTX· Turning Point Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TPTX (Turning Point Therapeutics Inc.) and more on Quantisnow.